Cytotoxic triterpenoids from Ganoderma lucidum

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Michael C. Alley, Dominic A. Scudiero, Anne Monks et al. · PubMed · 1988 · 3.1K citations

Medicine, Oncology, Pharmacology +14

Triterpenes from the Spores of Ganoderma lucidum and Their Inhibitory Activity against HIV-1 Protease.

Norio Nakamura, Hirotsugu Miyashiro, Ki‐Whan Bae et al. · Chemical and Pharmaceutical Bulletin · 1998 · 280 citations · Full text

Life Sciences, Biology, Microbiology +15

Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.

Aiko Morigiwa, Katsuaki Kitabatake, Yoshinori Fujimoto et al. · Chemical and Pharmaceutical Bulletin · 1986 · 220 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +11

Proteomics Characterization of the Cytotoxicity Mechanism of Ganoderic Acid D and Computer-automated Estimation of the Possible Drug Target Network

Qing‐Xi Yue, Zhiwei Cao, Shuhong Guan et al. · Molecular & Cellular Proteomics · 2007 · 181 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes.

Hiroshi Kohda, WAKAKO TOKUMOTO, KIYOE SAKAMOTO et al. · Chemical and Pharmaceutical Bulletin · 1985 · 179 citations · Full text

Medicine, Biochemistry, Pharmacology +14